1. Home
  2. PRTA vs MITK Comparison

PRTA vs MITK Comparison

Compare PRTA & MITK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$10.73

Market Cap

472.1M

Sector

Health Care

ML Signal

HOLD

Logo Mitek Systems Inc.

MITK

Mitek Systems Inc.

HOLD

Current Price

$8.87

Market Cap

420.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRTA
MITK
Founded
2012
1983
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
472.1M
420.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRTA
MITK
Price
$10.73
$8.87
Analyst Decision
Buy
Strong Buy
Analyst Count
9
2
Target Price
$17.71
$13.50
AVG Volume (30 Days)
578.4K
358.5K
Earning Date
11-06-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.33
Revenue
$11,786,000.00
$178,134,000.00
Revenue This Year
N/A
$4.11
Revenue Next Year
$672.02
$7.52
P/E Ratio
N/A
$26.54
Revenue Growth
N/A
6.98
52 Week Low
$4.32
$6.93
52 Week High
$17.66
$11.78

Technical Indicators

Market Signals
Indicator
PRTA
MITK
Relative Strength Index (RSI) 57.52 43.01
Support Level $9.90 $8.63
Resistance Level $10.91 $9.12
Average True Range (ATR) 0.53 0.26
MACD 0.00 0.00
Stochastic Oscillator 72.39 34.56

Price Performance

Historical Comparison
PRTA
MITK

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About MITK Mitek Systems Inc.

Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.

Share on Social Networks: